Prescription to over-the-counter deregulation in Canada: Are we ready for it, or do we need to be?

Lynd, Larry D.; Taylor, Jeff; Dobson, Roy; Willison, Donald J.

doi:10.1503/cmaj.050586

Cited by 10 publications

(8 citation statements)

References 5 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The explanations for this increase relate to socio-cultural and political issues linked to healthcare and technological advances in this area. This includes issues with a greater supply and expanded access to health services, greater participation by medications in healthcare, expansion of the therapeutic armamentarium, changes in treatment approaches, and prescription habits 10,12 , in addition to growing availability of over-the-counter drugs 26 .…”

Section: Discussionmentioning

confidence: 99%

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

et al. 2011

View full text Add to dashboard Cite

This study examined differences in the use of medications in two birth cohorts (born from 1916 to 1926 and from 1927 to 1937) wave, in 2008 (n = 620). The number of medications currently consumed (mean = 4.6 and 3.4, respectively) and prevalence of polypharmacy (46.6% and 29.1%, respectively) The high prevalence of chronic illnesses among the elderly is associated with high consumption of medications by this population group 3 . In the elderly population, the risks associated with consumption of medications compete with the expected benefits, due to the physiological changes proper to aging, including the decrease in muscle mass and body water, with effects on the pharmacodynamics and pharmacokinetics of medications. Thus, unwanted effects (adverse effects and drug-drug interactions) are more likely to occur 4 .The prevalence of polypharmacy is high in the elderly 5,6,7 , and is one of the strongest predictors of health problems associated with use of medications 4 . Polypharmacy is defined as the use of multiple medications, a basically quantita-ARTIGO ARTICLE Loyola Filho AI et al.

show abstract

Section: Discussionmentioning

confidence: 99%

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

et al. 2011

View full text Add to dashboard Cite

show abstract

“…22 The United Kingdom has indicated that it is considering a list of Ͼ100 individual drugs that also may move to OTC. 23 However, the release of OTC simvastatin in the United Kingdom met its share of controversy. Critics have questioned the clinical efficacy of the dosage approved, and consumer groups have challenged the marketing of the product.…”

Section: Discussionmentioning

confidence: 99%

Over-The-Counter Statins Are Worth Considering in Primary Prevention of Cardiovascular Disease

Gotto

2006

Circulation

View full text Add to dashboard Cite

“…73 Concerns have also been raised about the public' s perceptions of a broadening role of pharmacists and other health care professionals. 79 Traditionally, the general practitioner has been the gatekeeper to the health care system, with control over access to most services, including drug therapy for chronic diseases. A weakening of this role would in some circumstances eliminate the need for a general practitioner visit, at least after the initial diagnosis and receipt of the first prescription.…”

Section: Issues With Expanded Roles For Pharmacistsmentioning

confidence: 99%

“…Because a visit to a general practitioner and the ensuing receipt of a prescription potentially reinforces the patient' s understanding of the need for therapy, shifting the prescribing of medications for chronic diseases to other health care professionals may negatively affect the patient' s perception of the need for and effectiveness of medication. 79 This has significant implications for the safety and quality of care.…”

Section: Issues With Expanded Roles For Pharmacistsmentioning

confidence: 99%

Doctor and pharmacist — back to the apothecary!

Liaw¹,

Peterson²

2009

Aust. Health Review

View full text Add to dashboard Cite

The Australian National Medicines Policy embodies four tenets: availability, quality, safety and efficacy of medicines; timely access to affordable medicines; quality use of medicines (QUM); and a responsible and viable medicines industry. The promotion of QUM requires a multidisciplinary approach, including contributions from government, the pharmaceutical industry, health professionals, consumers and academia. However, there are significant tensions and unintended effects associated with the multidisciplinary approach, especially with the relationships between prescribers and dispensers of medicines.The general practitioner and the pharmacist share a common ancestor -the apothecary. The separation of dispensing from prescribing, which began in medieval Europe and 19th century England, reframed and confined the patient-doctor relationship to one of diagnosis, prescription and non-drug management. The role of pharmacists was limited to dispensing, though the present trend is for their responsibilities to be widened. Historical antecedents, the contribution of an increasing number of actors to the costs of health care, universal health insurance and an evolving regulatory framework, are among the factors influencing doctor-pharmacist relations.The prescribing and dispensing of medicines must be guided by an ethical clinical governance structure encompassing health professionals, regulators, the pharmaceutical industry and consumers. There must be close monitoring of safety and effectiveness, and promotion of quality use of medicines and improved patient outcomes. Ongoing training and professional development, within and across professional boundaries, is essential to support harmonious and cost-effective interprofessional practice. The approach must be "apothecarial" with complementary roles and responsibilities for the prescriber and dispenser within the patient-clinician therapeutic relation- ship, and not adversarial.

show abstract

Prescription to over-the-counter deregulation in Canada: Are we ready for it, or do we need to be?

Cited by 10 publications

References 5 publications

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

Over-The-Counter Statins Are Worth Considering in Primary Prevention of Cardiovascular Disease

Doctor and pharmacist — back to the apothecary!

Contact Info

Product

Resources

About

Prescription to over-the-counter deregulation in Canada: Are we ready for it, or do we need to be?

Cited by 10 publications

References 5 publications

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

Birth cohort differences in the use of medications in a Brazilian population of older elderly: the Bambuí cohort study of aging (1997 and 2008)

Over-The-Counter Statins Are Worth Considering in Primary Prevention of Cardiovascular Disease

Doctor and pharmacist &mdash; back to the apothecary!

Contact Info

Product

Resources

About

Doctor and pharmacist — back to the apothecary!